Shanghai Enkai Cell Technology Co., Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shanghai Enkai Cell Technology Co., Ltd - overview
Established
2020
Location
Shanghai, Shanghai, China
Primary Industry
Biotechnology
About
Established in 2020 and based in Shanghai, China, Shanghai Enkai Cell Technology Co. , Ltd is a cellular drug discovery and development company. The founder of this company, Zhigang Tian, is the founding director of the Institute of Immunology at the University of Science and Technology of China (USTC) and director of the Key Laboratory of Innate Immunity and Chronic Diseases at the Chinese Academy of Sciences (CAS). In November 2024, it closed a series A++ funding.
The company’s main business is the R&D and production of innovative cell drugs based on NK cells. The company’s self-developed products include a series of original intelligent NK cell products under the ABCDE-NK® strategic platform, such as technologies and products in four major categories and twelve series. Its products are used in the field of treating major clinical diseases. Shanghai Enkai Cell Technology Co.
, Ltd generates revenue by providing NK cell-based immunotherapy solutions and related cell products. The company will use the series A++ funding to accelerate the development and clinical trial process of the pipeline of cellular drug products under development. In July 2025, Shanghai Enkai Cell Technology Co. , Ltd raised nearly CNY 100 million of Series A+++ funding from new investor Pudong Capital and Zhongke Xianjin Fund.
Current Investors
Shanghai Zhangjiang Technology Venture Investment Co.,Ltd., Huagai Capital, Qiaojing Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.nk-celltech.com
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Shanghai Enkai Cell Technology Co., Ltd - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer & General Manager | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.